Boston Scientific Dl 01 Aktie - BSX

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

89,50

Gebot

89,00

Fragen

89,50

Volumen

1.464

87,00 Tagesbereich 89,50

58,00 52-Wochen-Bereich 105,00

Marktkapitalisierung

132,082B

Handelsende

88,00

Handelsbeginn

88,00

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

5.107

Ausgegebene Aktien

1.475.778.104

Dividendenrendite

Kurs-Gewinn-Verhältnis

77,38

Gewinn pro Aktie (EPS)

1,26

Erlöse

16,75B

Nettogewinn

1,85B

Sektor

Surgical,med Instr,apparatus

Branche

Surgical,med Instr,apparatus

Website

www.bostonscientific.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Boston Scientific Dl 01 is listed in the Surgical,med Instr,apparatus sector of the Tradegate (DE) with ticker BSX. The last closing price for Boston Scientific Dl 01 was 88,00 €. Over the last year, Boston Scientific Dl 01 shares have traded in a share price range of 58,00 € to 105,00 €.

Boston Scientific Dl 01 currently has 1.475.778.104 shares in issue. The market capitalisation of Boston Scientific Dl 01 is 129,87 € billion. Boston Scientific Dl 01 has a price to earnings ratio (PE ratio) of 77.38.

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6...

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...

Boston Scientific Announces Schedule for European Society of Cardiology Congress

NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-3	-3.24324324324	92.5	93.5	85	7549	88.39732959	DE
4	-12.5	-12.2549019608	102	102	85	5738	94.90079292	DE
12	4	4.6783625731	85.5	105	84	5107	95.0333814	DE
26	14	18.5430463576	75.5	105	73.5	3774	89.91361182	DE
52	29.22	48.4737889847	60.28	105	58	2339	85.52535389	DE
156	51.11	133.133628549	38.39	105	33.42	983	78.55733629	DE
260	59.74	200.739247312	29.76	105	28.93	745	76.71366348	DE

BSX - Frequently Asked Questions (FAQ)

What is the current Boston Scientific Dl 01 share price?

The current share price of Boston Scientific Dl 01 is 89,50 €

How many Boston Scientific Dl 01 shares are in issue?

Boston Scientific Dl 01 has 1.475.778.104 shares in issue

What is the market cap of Boston Scientific Dl 01?

The market capitalisation of Boston Scientific Dl 01 is EUR 129,87B

What is the 1 year trading range for Boston Scientific Dl 01 share price?

Boston Scientific Dl 01 has traded in the range of 58,00 € to 105,00 € during the past year

What is the PE ratio of Boston Scientific Dl 01?

The price to earnings ratio of Boston Scientific Dl 01 is 77,38

What is the cash to sales ratio of Boston Scientific Dl 01?

The cash to sales ratio of Boston Scientific Dl 01 is 8,56

What is the reporting currency for Boston Scientific Dl 01?

Boston Scientific Dl 01 reports financial results in USD

What is the latest annual turnover for Boston Scientific Dl 01?

The latest annual turnover of Boston Scientific Dl 01 is USD 16,75B

What is the latest annual profit for Boston Scientific Dl 01?

The latest annual profit of Boston Scientific Dl 01 is USD 1,85B

What is the registered address of Boston Scientific Dl 01?

The registered address for Boston Scientific Dl 01 is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Boston Scientific Dl 01 website address?

The website address for Boston Scientific Dl 01 is www.bostonscientific.com

Which industry sector does Boston Scientific Dl 01 operate in?

Boston Scientific Dl 01 operates in the SURGICAL,MED INSTR,APPARATUS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GTYGateway Real Estate AG	0,494 € (105,83%)	5,75k
SS1ARadius Recycling Inc	25,80 € (104,76%)	2,2k
W4VAlphaGen Intelligence Corp	0,01 € (100,00%)	30k
4X0Steyr Motors AG	90,00 € (65,14%)	123,85k
LSXLS Telcom AG	7,00 € (48,31%)	188,67k
L09Lithium Energi Exploration Inc	0,0065 € (-38,10%)	38,25k
1RR1Rokmaster Resources Corp	0,009 € (-37,93%)	6,1k
S09Sutro Biopharma Inc	0,835 € (-29,83%)	6,7k
27N0Cannovum Cannabis AG	0,202 € (-27,86%)	527
CNWCodon AG	0,0185 € (-27,45%)	2k
D7GNel ASA	0,239 € (-14,18%)	19,51M
RQ0DWave Quantum Inc	9,104 € (43,28%)	4,47M
DRHDroneShield Limited	0,643 € (11,44%)	3,59M
TKAThyssenkrupp AG	8,70 € (0,05%)	2,32M
PF8European Lithium Limited	0,0286 € (10,00%)	1,83M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Boston Scientific Dl 01 (BSX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Boston Scientific Dl 01

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

BSX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Boston Scientific Dl 01 (BSX) Börsenkurse

Boston Scientific Dl 01 (BSX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Boston Scientific Dl 01

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

BSX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen